FDA Inspection 998353 — American Red Cross Blood Services Southwest Region
The FDA completed an inspection of American Red Cross Blood Services Southwest Region on Jan 19, 2017 in Dallas, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 19, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Dallas, TX (United States)